Daan Gene Co., Ltd. (SHE:002030)

China · Delayed Price · Currency is CNY

5.55

+0.11 (2.02%)

Jun 18, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biological Products and Related Business	727.61M	820.60M	1.15B	12.01B	-
Biological Products and Related Business Growth	-11.33%	-28.57%	-90.43%	-	-
Financial Business	30.38M	32.43M	32.04M	35.90M	-
Financial Business Growth	-6.32%	1.20%	-10.73%	-	-
Offset of Business	-324.36K	-	-	-	-
Total	757.66M	853.02M	1.18B	12.05B	-
Total Growth	-11.18%	-27.76%	-90.20%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	757.66M	853.02M	1.18B	12.05B	7.66B
China Growth	-11.18%	-27.76%	-90.20%	57.17%	43.49%
Total	757.66M	853.02M	1.18B	12.05B	7.66B
Total Growth	-11.18%	-27.76%	-90.20%	57.17%	43.49%